NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
78 hedge funds and large institutions have $45.1M invested in Niagen Bioscience, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
+11
Holders Change %
+16.42%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
28
Increased
21
Reduced
15
Closed
16
Calls
$379K
Puts
$173K
Net Calls
+$206K
Net Calls Change
-$48K
Top Buyers
| 1 |
BlackRock
New York
|
+$6.04M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.56M |
| 3 |
State Street
Boston,
Massachusetts
|
+$997K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$924K |
| 5 |
JPMorgan Chase & Co
New York
|
+$682K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$1.07M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$938K |
| 3 |
Jane Street
New York
|
-$561K |
| 4 |
HF
HRT Financial
New York
|
-$455K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$422K |
